These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Mechanisms of resistance against experimental Trypanosoma cruzi infection: the importance of antibodies and antibody-forming capacity in the Biozzi high and low responder mice. Kierszenbaum F; Howard JG J Immunol; 1976 May; 116(5):1208-11. PubMed ID: 818311 [TBL] [Abstract][Full Text] [Related]
25. Trypanosoma cruzi antibodies in mice infected with different strains of T.cruzi. Peralta JM; Filardi L; Loures MA; Torres ST J Parasitol; 1980 Apr; 66(2):342-4. PubMed ID: 6771373 [No Abstract] [Full Text] [Related]
26. One fate of bloodstream trypomastigote forms of Trypanosoma cruzi after immune clearance: an ultrastructural study. Umekita LF; Carneiro SM; Sesso A; Mota I J Parasitol; 1999 Oct; 85(5):867-72. PubMed ID: 10577722 [TBL] [Abstract][Full Text] [Related]
27. Trypanosoma cruzi: role of macrophage membrane components in the phagocytosis of bloodstream forms. Alcantara A; Brener Z Exp Parasitol; 1980 Aug; 50(1):1-6. PubMed ID: 6771154 [No Abstract] [Full Text] [Related]
28. Macrophages in inflammation and infection. Dannenberg AM N Engl J Med; 1975 Sep; 293(10):489-93. PubMed ID: 1097912 [No Abstract] [Full Text] [Related]
29. Experimental Chagas disease: phagocytosis of apoptotic lymphocytes deactivates macrophages and fuels parasite growth. Lopes MF; DosReis GA Apoptosis; 2000 Jun; 5(3):221-4. PubMed ID: 11225843 [No Abstract] [Full Text] [Related]
30. Resistance of Trypanosoma cruzi to killing by macrophages. Kress Y; Bloom BR; Wittner M; Rowen A; Tanowitz H Nature; 1975 Oct; 257(5525):394-6. PubMed ID: 809716 [No Abstract] [Full Text] [Related]
31. In vivo and in vitro interaction of Trypanosoma cruzi with mouse macrophages and heart muscle cells--film presentation. Ax W; Dyonysius J; Hungerer KD Adv Exp Med Biol; 1979; 114():673-6. PubMed ID: 111486 [No Abstract] [Full Text] [Related]
33. Mouse as a model for Chagas disease: does mouse represent a good model for Chagas disease? Costa SC Mem Inst Oswaldo Cruz; 1999; 94 Suppl 1():269-72. PubMed ID: 10677731 [No Abstract] [Full Text] [Related]
34. Trypanosoma cruzi: uptake and intracellular fate in normal and activated cells. Nogueira N; Cohn Z Am J Trop Med Hyg; 1977 Nov; 26(6 Pt 2):194-203. PubMed ID: 413447 [No Abstract] [Full Text] [Related]
35. Role of the mononuclear phagocytic system in the immune and nonspecific clearance of Trypanosoma cruzi bloodstream trypomastigotes. Umekita LF; Mota I Braz J Med Biol Res; 1989; 22(12):1489-95. PubMed ID: 2518161 [TBL] [Abstract][Full Text] [Related]
36. Marked increase in Ia-bearing macrophages during Trypanosoma cruzi infection. Behbehani K; Pan SC; Unanue ER Clin Immunol Immunopathol; 1981 May; 19(2):190-5. PubMed ID: 6784986 [No Abstract] [Full Text] [Related]
37. Immunological properties of a trypanosomal lipopolysaccharide and its effects on the infection with Trypanosoma (Schizotrypanum) cruzi. Kierszenbaum F; Budzko DB Immunol Commun; 1973; 2(3):265-76. PubMed ID: 4200533 [No Abstract] [Full Text] [Related]
38. An immunocytotoxic assay for Trypanosoma cruzi. Kuhn RE; Vaughn RT Int J Parasitol; 1976 Apr; 6(2):129-34. PubMed ID: 816747 [No Abstract] [Full Text] [Related]
39. The lysis of Trypanosoma cruzi epimastigotes by eosinophils and neutrophils. López AF; Moreno MM; Sanderson CJ Int J Parasitol; 1978 Dec; 8(6):485-9. PubMed ID: 107139 [No Abstract] [Full Text] [Related]
40. Depletion of L3T4+ T lymphocytes during acute Trypanosoma cruzi infection abolish macrophage and B lymphocyte activation but not tissue inflammatory reaction. Russo M; Minoprio P; Coutinho A; Hontebeyrie-Joskowicz M Mem Inst Oswaldo Cruz; 1988 Nov; 83 Suppl 1():527-38. PubMed ID: 2908130 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]